Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease.
Hatem ElalfyM A El-MaksoudS AbedM A El AzizA Z ElsamanoudyS M Abo El-KhairM A MohamedW ElkashefK ZalataR FaragM ArafaPublished in: British journal of biomedical science (2019)
Keyphrases